Table 2.

Clinical features of probiotic group (N/A: Not applicable).

Treatment case group	Gender	Age	Moderate and severe pneumonia	Steroid and LWMAH	Hospitalization period (Day)	Specific treatment (Sp) (anti-IL-1,Anti-IL-6,Plazma)	Antibiotic	Antibiotic type	Dead	Thorax CT resolution 6 days of hospitalization (posttreatment 3 day)	Thorax CT resolution on 3 weeks	Hospitalization IL-6 levels (pg/ml)	3 weeks ıl-6 level
1	F	45	Moderate	Yes	7	No	No		No	Yes	Yes	62	5
2	F	47	Moderate	Yes	6	No	No		No	Yes	Yes	79	7
3	M	51	Moderate	Yes	7	No	No		No	Yes	Yes	27	3
4	F	36	Severe	Yes	8	No	Yes	Levofloksasin	No	Yes	Yes	156	4
5	M	41	Moderate	Yes	6	No	No		No	Yes	Yes	124	7
6	M	71	Severe	Yes	9	No	Yes	Levofloksasin	No	Yes	N/A	78	N/A
7	F	60	Moderate	Yes	7	No	No		No	No	N/A	56	N/A
8	F	61	Severe	Yes	8	No	Yes	Levofloksasin	No	No	Yes	188	8
9	F	45	Moderate	Yes	9	No	Yes	Levofloksasin	No	Yes	Yes	94	4
10	M	66	Moderate	Yes	7	No	Yes	Levofloksasin	No	Yes	Yes	116	6
11	M	44	Moderate	Yes	6	No	No		No	Yes	Yes	246	6
12	F	50	Moderate	Yes	6	No	No		No	Yes	N/A	135	N/A
13	F	50	Severe	Yes	9	No	Yes	Levofloksasin	Yes	No	N/A	486	N/A
14	M	65	Severe	Yes	8	No	No		No	No	Yes	106	10
15	F	45	Moderate	Yes	7	No	Yes		No	Yes	N/A	55	N/A
16	M	44	Moderate	Yes	7	No	Yes		No	Yes	N/A	79	N/A
17	M	73	Moderate	Yes	8	No	Yes	Levofloksasin	No	Yes	N/A	24	N/A
18	M	55	Severe	Yes	9	No	Yes	Levofloksasin	No	No	Yes	110	9
19	M	49	Moderate	Yes	8	No	Yes		No	Yes	Yes	56	6
20	M	73	Severe	Yes	9	No	Yes	Levofloksasin	No	No	Yes	88	5